the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Vaccines: The World Market

Published by Kalorama Information Contact us : +1-860-674-8796
Published 2007/02 Content info 305 pages
Product code KL48555
Price From  US $ 3995 Order/Price list
US $ 3995 PDF by E-mail (Single User License)
US $ 4395 Hard Copy
US $ 4795 PDF by E-mail (Single User License) & Hard Copy
US $ 4995 PDF by E-mail (10 User License)
US $ 7990 PDF by E-mail (Global Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

What are the trends that are fueling a new boom in vaccine production and sales? Why is an industry so commonly associated with children finding an increasing marketplace among adult populations? What makes this class of drugs likely to grow at a faster rate than other pharmaceutical products? These are among the questions answered in Kalorama' s in-depth report, Vaccines: The World Market.

With the historic success of vaccines in virtually eliminating diseases such as small pox and polio, and with their obvious benefit of preventing disease before it occurs, vaccines are a 9 billion dollar industry and new vaccines continue to be developed. Kalorama' s Vaccines: The World Market breaks down the market for pediatric and adult vaccines, providing background information, revenue numbers, and a discussion of critical trends that anyone seeking opportunities in vaccines will need to be aware of. Among the exhaustive information in this report, the following topics are discussed in detail:

  • Current and Forecasted Revenue Figures to 2012 for strategic planning and new product consideration.
  • Over 55 Tables and Figures for easy access to decision support information in proposals, internal memos and business plans.
  • Round-up of Key Vaccine Companies for benchmarking and marketplace knowledge.
  • Discussion of Major Issues and Trends such as vaccine safety and legislation affecting the market; current vaccine companies can use to plan, new entrants can use to quickly bring themselves up to speed on the marketplace and steer clear of problem areas.
  • Review of the Robust Vaccine Pipeline (nearly 200+ drugs in development) and how they are expected to affect the market, so that executives can adjust business decisions to the most likely market scenario.

Current revenues and revenue forecasts to 2012 are included for the following pediatric vaccine categories:

  • DTaP & DTP Vaccines
  • Hep Vaccines
  • HiB Vaccines
  • MMR Vaccines
  • Combination Vaccines
  • Pneumococcal Vaccines
  • Polio Vaccines
  • Varicella Vaccines
  • Other Pediatric Vaccines

As well as Revenues and Forecasts to 2012 for the following adult vaccine categories:

  • Influenza Vaccines
  • Hepatitis Vaccines
  • Pneumococcal Vaccines
  • Travel, DT and other Adult Vaccines

Additionally, this report provides current market size and forecasts the following cancer vaccines:

  • Breast Cancer
  • Cervical Cancer
  • Colon/Rectal Cancer
  • Lung
  • Melanoma
  • Prostate
  • Other cancers.
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.